WTC
HQL

WhitTier Trust Company’s abrdn Life Sciences Investors HQL Stock Holding History

WhitTier Trust Company’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$629 Buy
+37
New +$618 ﹤0.01% 1358

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

WhitTier Trust Company's HQL Position: Q1 2026 in Review

WhitTier Trust Company opened a new position in abrdn Life Sciences Investors (HQL) in Q1 2026: 37 shares worth $629. The stake represents ﹤0.01% of the portfolio and ranks #1358 among its holdings.

86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • WhitTier Trust Company held 37 shares of abrdn Life Sciences Investors worth $629 as of Q1 2026.
  • abrdn Life Sciences Investors was a new WhitTier Trust Company position in Q1 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of WhitTier Trust Company's portfolio in Q1 2026, its #1358 holding.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on WhitTier Trust Company's 13F filing for Q1 2026, filed 28 Apr 2026.